Related Experiment Video
Updated: Jun 23, 2025

Fetal Echocardiography and Pulsed-wave Doppler Ultrasound in a Rabbit Model of Intrauterine Growth Restriction
Published on: June 29, 2013
Molecular regulators of defective placental and cardiovascular development in fetal growth restriction
Anandita Umapathy1, Alys Clark1,2, Arvind Sehgal3
1Department of Obstetrics and Gynaecology, Faculty of Medical and Health Sciences, University of Auckland, New Zealand.
Insights
Placental insufficiency causes fetal growth restriction (FGR), impacting fetal development and increasing later-life chronic disease risk. Understanding shared placental and heart development factors is crucial for FGR research.
Area of Science:
- Obstetrics and Gynecology
- Developmental Biology
- Cardiovascular Science
Background:
- Placental insufficiency is a primary cause of fetal growth restriction (FGR).
- FGR leads to poor fetal growth and increased risks of chronic diseases later in life.
- Placental and cardiac development are interconnected, suggesting FGR impacts heart development.
Purpose of the Study:
- To review key molecular factors common to placental and cardiovascular development.
- To understand their role in FGR and associated developmental defects.
Main Methods:
- Literature review of growth factors, angiogenic molecules, and transcription factors.
- Analysis of shared pathways in placental and cardiac development.
Main Results:
- Identified key molecular players (growth factors, angiogenic molecules, transcription factors) implicated in both placental and cardiac development.
- Highlighted their common role in FGR pathogenesis.
Conclusions:
- Shared molecular mechanisms are critical in FGR, affecting both placental function and fetal heart development.
- Targeting these shared pathways may offer therapeutic strategies for FGR and its long-term consequences.
Abstract:
Placental insufficiency is one of the major causes of fetal growth restriction (FGR), a significant pregnancy disorder in which the fetus fails to achieve its full growth potential in utero. As well as the acute consequences of being born too small, affected offspring are at increased risk of cardiovascular disease, diabetes and other chronic diseases in later life. The placenta and heart develop concurrently, therefore placental maldevelopment and function in FGR may have profound effect on the growth and differentiation of many organ systems, including the heart. Hence, understanding the key molecular players that are synergistically linked in the development of the placenta and heart is critical. This review highlights the key growth factors, angiogenic molecules and transcription factors that are common causes of defective placental and cardiovascular development.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Teratogenicity
Master Transcription Regulators
Negative Regulator Molecules
Development of Blood Vessels
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...

